WATERMARK: Pharmaceutical, Biotech and Med Devices Safety Oversight

Home

WATERMARK DSMB

Critical Independence

Committee Composition

Data Administration

Regulatory Audits

Adjudication Panels

WATERMARK Advantage

Post-Market Safety

Patient Outcomes Registry

Collect Independent Data

Device Safety

Articles/Press Releases

Corporate Overview

WATERMARK Contact

WATERMARK Communications

DSMB extranet access

DSMB, IDMC, Adjudication Panels, Post-Market Safety, Outcome Registries.

Articles for Download
Please feel free to download any of the articles below.  Simply click to open and save.
Risk Mitigation and Management
Document
Watermark- Risk Mitigation & Outcome Registries		Document
So You Have an Outcomes Registry....Now What?
Safety Oversight
Document
DSMB & Sarbanes-Oxley		Document
Future of Safety Monitoring		Document
DSMB vs. IRB
Document
DSMB- Critical Independence		Document
Post-Market Safety Surveillance		Document
FDA Guidance for DSMB 2006
Device Safety
Document
Safety of Marketed Medical Devices
Document
Postmarket is CDRH's Top Priority		Document
FDAs Tough Cop Stance on MDR Enforcement		  
Gift Registries
Document
AMA Gift Guidelines		Document
Massachusetts- Physician Stipends		Document
Regulating Industry Payments
Document
Drug Samples Role as Marketing Tool		Document
Minn Health System Purges Trinkets
Document
Watermark- Gift Registries		Document
MA Regulations for Industry		  
MSL
Document
Pfizer Fined- September 2009		Document
MSL- Delicate Balance
Document
Eli Lilly Zyprexa Litigation		    
Press Release Links for Safety Oversight

SmartBrief 01/09/2008

The National Agency for Food and Drug Administration and Control (NAFDAC)

Business Wire 01/09/2008

PRWeb 01/09/2008
Powered by Watermark Research Partners, 2009
copyright, all rights reserved.